| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00534-010-0293-1 |
| P698 | PubMed publication ID | 20503059 |
| P50 | author | Yuji Nakamoto | Q91456447 |
| Shinji Uemoto | Q91614513 | ||
| Kentaro Yasuchika | Q107527147 | ||
| Kojiro Taura | Q110418581 | ||
| Etsuro Hatano | Q110418582 | ||
| P2093 | author name string | Iwao Ikai | |
| Tatsuya Higashi | |||
| Koji Kitamura | |||
| Satoru Seo | |||
| Ryuichiro Doi | |||
| Masato Narita | |||
| Takashi Nitta | |||
| Kenya Yamanaka | |||
| P2860 | cites work | Biliary tract cancers. | Q33760399 |
| Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection | Q33935808 | ||
| Cholangiocarcinoma. | Q33990595 | ||
| Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates | Q34322673 | ||
| Positron emission tomography imaging in oncology | Q34391770 | ||
| Whole-body FDG-PET imaging in the management of patients with cancer. | Q34525490 | ||
| Pathological appraisal of lines of resection for bile duct carcinoma | Q34894190 | ||
| Pearls and pitfalls in interpretation of abdominal and pelvic PET-CT. | Q36594518 | ||
| FDG-PET. A possible prognostic factor in head and neck cancer | Q36644134 | ||
| Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature. | Q36688262 | ||
| Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment | Q37478218 | ||
| Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma | Q37571682 | ||
| Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. | Q38504053 | ||
| [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer | Q43521805 | ||
| Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer | Q43601169 | ||
| FDG PET in the diagnosis of hilar cholangiocarcinoma | Q43801540 | ||
| Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer | Q44098348 | ||
| FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. | Q44149763 | ||
| Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer | Q44206304 | ||
| Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma | Q44744688 | ||
| Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. | Q46543500 | ||
| Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture | Q46600275 | ||
| Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging | Q46821567 | ||
| 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer | Q46835876 | ||
| Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. | Q53288156 | ||
| Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma | Q57823650 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | positron emission tomography | Q208376 |
| P304 | page(s) | 39-46 | |
| P577 | publication date | 2010-05-26 | |
| P1433 | published in | Journal of Hepato-biliary-Pancreatic Sciences | Q25378879 |
| P1476 | title | Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer | |
| P478 | volume | 18 |
| Q43421343 | A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer |
| Q40554841 | Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis |
| Q38266166 | European Association of Endoscopic Surgeons (EAES) consensus statement on the use of robotics in general surgery |
| Q35915703 | Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications |
| Q41140995 | Nerve Growth Factor Expression Is Not Associated with Perineural Invasion in Extrahepatic Cholangiocarcinoma |
| Q51802126 | Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies. |
| Q33639345 | Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer |
| Q53063502 | Prognostic and predictive value of metabolic tumor volume on (18)F-FDG PET/CT in advanced biliary tract cancer treated with gemcitabine/oxaliplatin with or without erlotinib. |
| Q53051639 | Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma. |
| Q47843423 | The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma |
| Q41880189 | Tubular adenoma of the common bile duct with uptake in (18)F-FDG PET: A case report |
Search more.